Top Buy Stocks
Sign In
NASDAQ:BIOC
Delisted
Biocept Stock News
Invest in BIOC
$0.435
+0 (+0%)
At Close: Jan 23, 2024
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CSF--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with bre
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
08:00am, Friday, 08'th Sep 2023
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CSF--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing a
Biocept to Participate in the H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 05'th Sep 2023
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that management will
Biocept, Inc. (BIOC) Business Update Conference Call (Transcript)
08:38pm, Wednesday, 30'th Aug 2023
Biocept, Inc. (NASDAQ:BIOC ) Business Update Conference Call August 30, 2023 4:00 PM ET Company Participants Jody Cain - LHA Antonino Morales - President, CEO Dr. Barbara Blouw - VP, Clinical Developm
Biocept to Hold Business Update Conference Call on August 30, 2023
08:00am, Friday, 25'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call on August 30, 2023, beginning at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to provide a business u
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
07:20am, Friday, 25'th Aug 2023
Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.
Biocept Reports Second Quarter 2023 Financial Results
04:05pm, Monday, 14'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and six months ended June 30
Biocept CNSide assay takes the spotlight at 2023 SNO/ASCO CNS Cancer Conference
08:40am, Monday, 14'th Aug 2023
Biocept Inc (NASDAQ:BIOC) said that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 Society for Neuro-Oncology (SNO)/American Society for Clinical Oncology (ASC
Biocept's CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
08:00am, Monday, 14'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CSF--Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that i
Biocept Announces the Passing of Board Chair M. Faye Wilson
06:15pm, Thursday, 13'th Jul 2023
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CSF--Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”) announces that M. Faye Wilson, Board Chair, passed away unexpectedly on Monday, July 10. Th
Biocept appoints Antonino Morales as president and chief executive officer
08:14am, Wednesday, 21'st Jun 2023
Biocept Inc (NASDAQ:BIOC) has announced the appointment of Antonino Morales as its president and chief executive officer, effective immediately. Morales, who has been serving as the company's interim
Biocept Names Antonino Morales as President and Chief Executive Officer
04:15pm, Tuesday, 20'th Jun 2023
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CSF--Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, has named Antoni
Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
04:05pm, Wednesday, 14'th Jun 2023
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces that management will p
Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of the company's cerebrospinal fluid assay C
Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept's CNSide™ Versus Cytology
08:00am, Monday, 05'th Jun 2023
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #CNSide--Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces a po
